Elutia Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Elutia Inc 's inventory turnover ratio, the ratio that measures Elutia Inc 's ability to manage its supply chain, sequentially decreased to 1.75 in the second quarter 2026, which does not come as a surprise, as the Elutia Inc continue to experience headwinds, which also impact its supply chain. Elutia Inc 's average inventory processing period in the Jun 30 2026 quarter, has increased to 209 days, from 180 days, in the Mar 31 2026 quarter.

Within Healthcare sector 227 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 1135 in the first quarter 2026, to 1549.

ELUT Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Elutia Inc Market Share?

What is Inventory Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Inventory Turnover▼

None ▼

Inventory Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

ELUT Inventory Turnover Ratio	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Inventory Growth	-49.48 %	-38.01 %	-33.09 %	-44.65 %	68.31 %
Y / Y Cost of Sales Growth	-67.33 %	-66.67 %	-66.07 %	-66.67 %	0 %
Inventory Turnover Ratio (TTM)	1.75	2.03	2.36	2.85	3.05
ELUT's Total Ranking	# 1549	# 1135	# 1212	# 987	# 987
Average inventory processing period	209	180	155	128	120
Seq. Inventory Growth	-0.3 %	1.53 %	30.13 %	-61.64 %	22.33 %
Seq. Cost of Sales Growth	-2 %	-26.31 %	35.7 %	-66.67 %	0 %

Inventory Turnover Ratio Company Ranking
Within:	No.
Biotechnology & Pharmaceuticals Industry	# 18
Healthcare Sector	# 228
Overall Market	# 1549

Inventory Turnover Ratio Statistics
High	Average	Low
3.79	2.87	1.75
(Dec 31 2024)		(Jun 30 2026)

ELUT Company Profile >> Back to ELUT Efficiency Comparisons >> Compare ELUT Inventory Turnover Ratio to its Competitors

Financial Statements
Elutia Inc 's Inventories	$ 3 Millions	Visit ELUT's Balance sheet
Elutia Inc 's Cost of Revenues TTM	$ 4 Millions	Visit ELUT's Income Statement
What are ELUT's Sales?		Visit ELUT's Sales by Segment

Other Inventory Turnover Ratios
Elutia Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Biotechnology & Pharmaceuticals Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
ELUT's Inventory Turnover Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for ELUT's Competitors
Inventory Turnover Ratio for ELUT's Suppliers
Inventory Turnover Ratio for ELUT's Customers

You may also want to know
ELUT's Sales Growth Rates	ELUT's Pe Price to earnings ratio	ELUT's Receivables Turnover Ratio	ELUT's Stock Quote
ELUT's Net Income Growth Rates	ELUT's Ps Price to Sales ratio	ELUT's Sales per Employee	ELUT's Asset Turnover Ratio
ELUT's Net Margin	ELUT's Pb Price to Book ratio	ELUT's Financial Strength Ratios	ELUT's Dividend Payout Ratio

Companies with similar Inventory Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector	Inventory Turnover Ratio	Cost of revenues at quarter ending Jun 30 2026	Inventories at quarter ending Jun 30 2026
Idexx Laboratories Inc	4.44	$ 1,714.440 Millions	$ 386 Millions
Cryoport inc	4.40	$ 98.679 Millions	$ 22 Millions
Envista Holdings Corporation	4.37	$ 1,278.500 Millions	$ 293 Millions
Vericel Corporation	4.30	$ 77.922 Millions	$ 18 Millions
Myomo Inc	4.23	$ 14.262 Millions	$ 3 Millions
Adc Therapeutics Sa	4.17	$ 5.806 Millions	$ 1 Millions
Scilex Holding Company	4.08	$ 14.867 Millions	$ 4 Millions
Medinotec Inc	4.08	$ 4.736 Millions	$ 1 Millions
Alpha Teknova Inc	4.08	$ 28.288 Millions	$ 7 Millions
3m Company	4.07	$ 15,258.000 Millions	$ 3,754 Millions
Coherus Oncology inc	4.03	$ 15.822 Millions	$ 4 Millions
Electromed Inc	4.02	$ 14.133 Millions	$ 4 Millions
Novocure Limited	4.02	$ 166.921 Millions	$ 41 Millions
Koru Medical Systems Inc	3.97	$ 16.948 Millions	$ 4 Millions
Elite Pharmaceuticals Inc	3.95	$ 78.824 Millions	$ 20 Millions
Lftd Partners Inc	3.89	$ 29.233 Millions	$ 8 Millions
Pmgc Holdings Inc	3.87	$ 1.364 Millions	$ 0 Millions
Sonoma Pharmaceuticals Inc	3.83	$ 13.392 Millions	$ 3 Millions
Intelligent Bio Solutions Inc	3.80	$ 2.165 Millions	$ 1 Millions
Iridex Corp	3.80	$ 32.517 Millions	$ 9 Millions
Biocryst Pharmaceuticals Inc	3.69	$ 20.926 Millions	$ 6 Millions
Abbvie Inc	3.66	$ 18,365.000 Millions	$ 5,016 Millions
Teva Pharmaceutical Industries Limited	3.66	$ 8,232.000 Millions	$ 2,250 Millions
Neuraxis Inc	3.55	$ 0.783 Millions	$ 0 Millions
Beyond Air Inc	3.51	$ 6.447 Millions	$ 2 Millions
Nexgel Inc	3.49	$ 7.577 Millions	$ 2 Millions
Lifeward ltd	3.47	$ 13.976 Millions	$ 4 Millions
Tandem Diabetes Care Inc	3.46	$ 456.703 Millions	$ 132 Millions
Baxter International Inc	3.46	$ 8,020.000 Millions	$ 2,317 Millions
Mirum Pharmaceuticals Inc	3.40	$ 85.221 Millions	$ 25 Millions

Date modified: 2026-09-08T17:33:17+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.